Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

delpino2017_2646.pdf (191.27 KB)

Document type

Article

Version

Accepted version

Publication date

2017-07-21

Publication license

cc-by-nc-nd (c) Pino et al., 2017
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/115794

Comparison of the Analytical and Clinical Performance of Five Tests for the Detection of Human Papillomavirus Genital Infection

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

http://dx.doi.org/10.1016/j.jviromet.2017.07.009

Abstract

HPV-based screening provides greater protection against cervical cancer (CC) than cytology-based strategies. Currently, several molecular diagnostic assays for the detection of human papillomavirus (HPV) are available. In this study, we analyzed 5 different HPV testing and genotyping techniques (Hybrid Capture 2 [HC2; Qiagen, Hilden, Germany], AnyplexTMII HPV28 [Anyplex; Seegene, Seoul, Korea], Linear Array [Roche, Branchburg, NJ, USA], GP5+/6+ PCR-EIA-RH [Labo Bio-medical Products, Rijswijk, The Netherlands] and CLART2 [Genomica, Madrid, Spain]) in 295 women referred to the hospital Colposcopy Clinic from 2007 to 2008 due to positive HPV test results or an abnormal Pap test. DNA extraction for HPV genotyping was performed in cervical sample specimens after Pap test and HPV detection by HC2. The inclusion criteria were: (1) adequate cervical sampling with sufficient material for the Pap test and HPV detection and genotyping, and (2) colposcopically-directed biopsy and/or endocervical curettage. HC2 showed the highest sensitivity for high-grade squamous intraepithelial lesion and CC (HSIL+) detection (96.1%), but all the HPV genotyping tests showed a higher specificity. (Anyplex 86.8%; Linear Array 86.0%; GP5+/6+ 78.8%; CLART2 76.5%). The agreement between HC2 results and the other techniques was similar: 82.4%, kappa=0.650 for Anyplex; 83.4%, kappa=0.670 for Linear Array, 79.93%, kappa=0.609 for GP5+/6+ and 82.4%, kappa=0.654 for CLART2. HPV 16 and/or 18 infection was a risk factor for underlying HSIL+ in the univariate analysis. Anyplex showed the highest risk of underlying HSIL+ after positive HPV 16 and/or 18 tests (OR 31.1; 95% IC 12.1-80.0).

Subject

Papil·lomavirus, Genètica humana

Subject (English)

Papillomaviruses, Human genetics

Citation

Collections

Articles publicats en revistes (ISGlobal)

Citation

PINO SALADRIGUES, Marta del, et al. Comparison of the Analytical and Clinical Performance of Five
                Tests for the Detection of Human Papillomavirus Genital
                Infection. Journal of Virological Methods. 2017. ISSN 0166-0934. [consulted: 12 of August of 2026]. Available at: https://hdl.handle.net/2445/115794

Export metadata

JSON - METS

Share record